187 related articles for article (PubMed ID: 34769499)
1. Insights into Intra-Tumoral Heterogeneity: Transcriptional Profiling of Chemoresistant MPM Cell Subpopulations Reveals Involvement of NFkB and DNA Repair Pathways and Contributes a Prognostic Signature.
Cioce M; Sacconi A; Pass HI; Canino C; Strano S; Blandino G; Fazio VM
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769499
[TBL] [Abstract][Full Text] [Related]
2. A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations.
Canino C; Luo Y; Marcato P; Blandino G; Pass HI; Cioce M
Oncotarget; 2015 May; 6(14):12637-53. PubMed ID: 25868979
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.
Cortes-Dericks L; Froment L; Boesch R; Schmid RA; Karoubi G
BMC Cancer; 2014 Apr; 14():304. PubMed ID: 24884875
[TBL] [Abstract][Full Text] [Related]
4. Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma.
Cioce M; Canino C; Pass H; Blandino G; Strano S; Fazio VM
J Exp Clin Cancer Res; 2021 Nov; 40(1):344. PubMed ID: 34727953
[TBL] [Abstract][Full Text] [Related]
5. SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells.
Canino C; Mori F; Cambria A; Diamantini A; Germoni S; Alessandrini G; Borsellino G; Galati R; Battistini L; Blandino R; Facciolo F; Citro G; Strano S; Muti P; Blandino G; Cioce M
Oncogene; 2012 Jun; 31(26):3148-63. PubMed ID: 22020330
[TBL] [Abstract][Full Text] [Related]
6. Butein-instigated miR-186-5p-dependent modulation of TWIST1 affects resistance to cisplatin and bioenergetics of Malignant Pleural Mesothelioma cells.
Cioce M; Rutigliano D; Puglielli A; Fazio VM
Cancer Drug Resist; 2022; 5(3):814-828. PubMed ID: 36176750
[No Abstract] [Full Text] [Related]
7. Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin.
Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Segura-Carretero A; Joven J; Martin-Castillo B; Barrajón-Catalán E; Micol V; Bosch-Barrera J; Menendez JA
Cell Cycle; 2013 Nov; 12(21):3390-404. PubMed ID: 24047698
[TBL] [Abstract][Full Text] [Related]
8. Isolation of Chemoresistant Cell Subpopulations.
Canino C; Cioce M
Methods Mol Biol; 2016; 1379():139-50. PubMed ID: 26608297
[TBL] [Abstract][Full Text] [Related]
9. Butein impairs the protumorigenic activity of malignant pleural mesothelioma cells.
Cioce M; Canino C; Pulito C; Muti P; Strano S; Blandino G
Cell Cycle; 2012 Jan; 11(1):132-40. PubMed ID: 22185775
[TBL] [Abstract][Full Text] [Related]
10. Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment.
Chen R; Lee WC; Fujimoto J; Li J; Hu X; Mehran R; Rice D; Swisher SG; Sepesi B; Tran HT; Chow CW; Little LD; Gumbs C; Haymaker C; Heymach JV; Wistuba II; Lee JJ; Futreal PA; Zhang J; Reuben A; Tsao AS; Zhang J
Clin Cancer Res; 2020 Oct; 26(20):5477-5486. PubMed ID: 32816946
[TBL] [Abstract][Full Text] [Related]
11. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.
Shao C; Sullivan JP; Girard L; Augustyn A; Yenerall P; Rodriguez-Canales J; Liu H; Behrens C; Shay JW; Wistuba II; Minna JD
Clin Cancer Res; 2014 Aug; 20(15):4154-66. PubMed ID: 24907115
[TBL] [Abstract][Full Text] [Related]
12. Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM).
Lapidot M; Case AE; Weisberg EL; Meng C; Walker SR; Garg S; Ni W; Podar K; Hung YP; Carrasco RD; Knott A; Gokhale PC; Sharma S; Pozhitkov A; Kulkarni P; Frank DA; Salgia R; Griffin JD; Saladi SV; Bueno R; Sattler M
Br J Cancer; 2021 Aug; 125(4):582-592. PubMed ID: 34088988
[TBL] [Abstract][Full Text] [Related]
13. Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma.
Borchert S; Suckrau PM; Walter RFH; Wessolly M; Mairinger E; Steinborn J; Hegedus B; Hager T; Herold T; Eberhardt WEE; Wohlschlaeger J; Aigner C; Bankfalvi A; Schmid KW; Mairinger FD
Sci Rep; 2020 Oct; 10(1):18677. PubMed ID: 33122816
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.
Blondy T; d'Almeida SM; Briolay T; Tabiasco J; Meiller C; Chéné AL; Cellerin L; Deshayes S; Delneste Y; Fonteneau JF; Boisgerault N; Bennouna J; Grégoire M; Jean D; Blanquart C
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581053
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival.
Quetel L; Meiller C; Assié JB; Blum Y; Imbeaud S; Montagne F; Tranchant R; de Wolf J; Caruso S; Copin MC; Hofman V; Gibault L; Badoual C; Pintilie E; Hofman P; Monnet I; Scherpereel A; Le Pimpec-Barthes F; Zucman-Rossi J; Jaurand MC; Jean D
Mol Oncol; 2020 Jun; 14(6):1207-1223. PubMed ID: 32083805
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic alterations in malignant pleural mesothelioma cells in response to long‑term treatment with bullfrog sialic acid‑binding lectin.
Tatsuta T; Nakasato A; Sugawara S; Hosono M
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880588
[TBL] [Abstract][Full Text] [Related]
17. Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5.
Milosevic V; Kopecka J; Salaroglio IC; Libener R; Napoli F; Izzo S; Orecchia S; Ananthanarayanan P; Bironzo P; Grosso F; Tabbò F; Comunanza V; Alexa-Stratulat T; Bussolino F; Righi L; Novello S; Scagliotti GV; Riganti C
Int J Cancer; 2020 Jan; 146(1):192-207. PubMed ID: 31107974
[TBL] [Abstract][Full Text] [Related]
18. A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment.
Boumya S; Fallarini S; Siragusa S; Petrarolo G; Aprile S; Audrito V; La Motta C; Garavaglia S; Moro L; Pinton G
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047661
[TBL] [Abstract][Full Text] [Related]
19. HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome.
di Martino S; Amoreo CA; Nuvoli B; Galati R; Strano S; Facciolo F; Alessandrini G; Pass HI; Ciliberto G; Blandino G; De Maria R; Cioce M
Oncogene; 2018 Mar; 37(10):1369-1385. PubMed ID: 29311642
[TBL] [Abstract][Full Text] [Related]
20. Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma.
Stockhammer P; Ploenes T; Theegarten D; Schuler M; Maier S; Aigner C; Hegedus B
Lung Cancer; 2020 Jan; 139():124-132. PubMed ID: 31778960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
